Nhật Bản ghi nhận 13% học sinh có xu hướng trầm cảm do COVID-19

Riêng trong tháng 10 năm ngoái, có tới 13% học sinh từ bậc tiểu học đến trung học phổ thông ở Nhật Bản có xu hướng trầm cảm cần được chăm sóc y tế do ảnh hưởng của dịch COVID-19. Đây là kết quả khảo sát vừa được Trung tâm quốc gia về sức khỏe và phát triển trẻ em Nhật Bản công bố.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh